MONA XIAO: Open Payments
NPI 1841784931 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,168 in 58 payments from 19 companies in 2025. Trend: 2023 $622 · 2024 $1,029 · 2025 $1,168
Food & beverage: $1,168
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 7 | $168 |
| AstraZeneca Pharmaceuticals LP | 3 | $163 |
| Novo Nordisk Inc | 9 | $152 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| GlaxoSmithKline, LLC. | 5 | $84 |
| Amgen Inc. | 5 | $74 |
| ABBVIE INC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Braeburn Inc. | 2 | $35 |
Products named: Korlym, BREZTRI, JARDIANCE, TRELEGY ELLIPTA, OTEZLA, Ozempic, CAPLYTA, Wegovy.
Industry payments across NC — which companies pay providers there.
